受强制性开放获取政策约束的文章 - Veronika Temml了解详情
无法在其他位置公开访问的文章：10 篇
Pharmacophore modeling for COX-1 and-2 inhibitors with LigandScout in comparison to Discovery Studio
V Temml, T Kaserer, Z Kutil, P Landa, T Vanek, D Schuster
Future medicinal chemistry 6 (17), 1869-1881, 2014
强制性开放获取政策： Austrian Science Fund
Anti-tyrosinase activity of South African Aloe species and isolated compounds plicataloside and aloesin
M Mikayoulou, F Mayr, V Temml, A Pandian, I Vermaak, W Chen, ...
Fitoterapia 150, 104828, 2021
强制性开放获取政策： Austrian Science Fund, National Research Foundation, South Africa
Identification of the fungicide epoxiconazole by virtual screening and biological assessment as inhibitor of human 11β-hydroxylase and aldosterone synthase
M Akram, M Patt, T Kaserer, V Temml, W Waratchareeyakul, ...
The Journal of steroid biochemistry and molecular biology 192, 105358, 2019
强制性开放获取政策： Austrian Science Fund
Synthesis, inhibitory activity and in silico docking of dual COX/5-LOX inhibitors with quinone and resorcinol core
M Sisa, M Dvorakova, V Temml, V Jarosova, T Vanek, P Landa
European Journal of Medicinal Chemistry 204, 112620, 2020
强制性开放获取政策： Austrian Science Fund, European Commission
Discovery of carbazole derivatives as novel allosteric MEK inhibitors by pharmacophore modeling and virtual screening
D Xi, Y Niu, H Li, SM Noha, V Temml, D Schuster, C Wang, F Xu, P Xu
European Journal of Medicinal Chemistry 178, 802-817, 2019
强制性开放获取政策： Austrian Science Fund, 国家自然科学基金委员会
N-methylated diazabicyclo [3.2. 2] nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase
N Heise, S Friedrich, V Temml, D Schuster, B Siewert, R Csuk
European Journal of Medicinal Chemistry 227, 113947, 2022
强制性开放获取政策： Austrian Science Fund
Synthesis of new 4-phenylpyrimidine-2 (1H)-thiones and their potency to inhibit COX-1 and COX-2
W Seebacher, J Faist, A Presser, R Weis, R Saf, T Kaserer, V Temml, ...
European Journal of Medicinal Chemistry 101, 552-559, 2015
强制性开放获取政策： Austrian Science Fund
Highly potent and selective 5-lipoxygenase inhibition by new, simple heteroaryl-substituted catechols for treatment of inflammation
V Krauth, F Bruno, S Pace, PM Jordan, V Temml, MP Romano, H Khan, ...
Biochemical Pharmacology 208, 115385, 2023
强制性开放获取政策： Austrian Science Fund, German Research Foundation
Design and synthesis of functionalized 4-aryl-Catechol derivatives as new antiinflammtory agents with in vivo efficacy
F Bruno, V Krauth, SM Nabavi, V Temml, F Fratianni, G Spaziano, ...
European Journal of Medicinal Chemistry 243, 114788, 2022
强制性开放获取政策： Austrian Science Fund
SC‐560 and mofezolac isosteres as new potent COX‐1 selective inhibitors with antiplatelet effect
M Sisa, L Konečný, V Temml, A Carazo, P Mladěnka, P Landa
Archiv der Pharmazie 356 (5), 2200549, 2023
强制性开放获取政策： Austrian Science Fund, European Commission
可在其他位置公开访问的文章：50 篇
Discovery and resupply of pharmacologically active plant-derived natural products: A review
AG Atanasov, B Waltenberger, EM Pferschy-Wenzig, T Linder, ...
Biotechnology advances 33 (8), 1582-1614, 2015
强制性开放获取政策： Austrian Science Fund
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase
H Pein, A Ville, S Pace, V Temml, U Garscha, M Raasch, K Alsabil, ...
Nature communications 9 (1), 3834, 2018
强制性开放获取政策： German Research Foundation, Federal Ministry of Education and Research, Germany
Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin
AM Schaible, H Traber, V Temml, SM Noha, R Filosa, A Peduto, ...
Biochemical pharmacology 86 (4), 476-486, 2013
强制性开放获取政策： Austrian Science Fund
Impact of wines and wine constituents on cyclooxygenase‐1, cyclooxygenase‐2, and 5‐lipoxygenase catalytic activity
Z Kutil, V Temml, D Maghradze, M Pribylova, M Dvorakova, D Schuster, ...
Mediators of inflammation 2014 (1), 178931, 2014
强制性开放获取政策： Austrian Science Fund, European Commission
Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole
KR Beck, M Bächler, A Vuorinen, S Wagner, M Akram, U Griesser, ...
Biochemical pharmacology 130, 93-103, 2017
强制性开放获取政策： Swiss National Science Foundation, Austrian Science Fund
Structure-based molecular modeling in SAR analysis and lead optimization
V Temml, Z Kutil
Computational and structural biotechnology journal 19, 1431-1444, 2021
强制性开放获取政策： Austrian Science Fund
Discovery of potent soluble epoxide hydrolase (sEH) inhibitors by pharmacophore-based virtual screening
B Waltenberger, U Garscha, V Temml, J Liers, O Werz, D Schuster, ...
Journal of Chemical Information and Modeling 56 (4), 747-762, 2016
强制性开放获取政策： Austrian Science Fund
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolase
U Garscha, E Romp, S Pace, A Rossi, V Temml, D Schuster, S König, ...
Scientific reports 7 (1), 9398, 2017
强制性开放获取政策： German Research Foundation
Discovery of new liver X receptor agonists by pharmacophore modeling and shape-based virtual screening
V Temml, CV Voss, VM Dirsch, D Schuster
Journal of chemical information and modeling 54 (2), 367-371, 2014
强制性开放获取政策： Austrian Science Fund
Parallel in vitro and in silico investigations into anti-inflammatory effects of non-prenylated stilbenoids
V Leláková, K Šmejkal, K Jakubczyk, O Veselý, P Landa, J Václavík, ...
Food chemistry 285, 431-440, 2019
强制性开放获取政策： Austrian Science Fund
出版信息和资助信息由计算机程序自动确定